CHADDS FORD, Pa., Dec. 29, 2010 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has ...
WASHINGTON, Dec 29 (Reuters) - U.S. health regulators have approved Endo Pharmaceuticals Holding Inc and ProStrakan Group PLC's Fortesta testosterone gel to treat men with low levels of the hormone.
WASHINGTON (Reuters) - U.S. health regulators have approved Endo Pharmaceuticals Holding Inc and ProStrakan Group PLC's Fortesta testosterone gel to treat men with low levels of the hormone. The gel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback